(Center for Genomic Regulation) A research effort led by Eulàlia Martí at the Centre for Genomic Regulation reveals new molecular mechanisms of Huntington's chorea. The results, recently published in the Journal of Clinical Investigation, question the approaches used up to now for treatment of the disease. They also point to messenger RNA as a key pathogenic component that will make it possible to define new therapeutic strategies.
The messenger in Huntington’s disease
Please login to join discussion
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor
-
New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases